BCR-ABL (9:22) Quantitative - Whole Blood

BCR-ABL (9:22) Quantitative - Whole Blood


This test is used to help diagnose chronic myelogenous leukemia (CML) or a type of acute lymphoblastic leukemia (ALL). To monitor treatment and recurrence of disease.

This Test Includes

Observed copies of BCR-ABL1

Type of Translocation

Observed copies of ABL1

BCR - ABL International Scale Normalized copy number

BCR- ABL gene rearrangement


Test Instructions

Total parameters available: 1

Parameter Names:

  • BCR-ABL (9:22) Quantitative - Whole Blood

Test Instructions/Precautions:

  • Alcohol: Please abstain from alcohol before the test
  • Medication :Any pre-existing medication should only be stopped after consultation with the referring Physician
  • Fluids Allowed : Water only


Soft Copy (Portal/Email) : If the sample is collected before 12 noon then the report will get delivered as per Reporting Time / Maximum TAT (Turn Around Time) indicated with the test. For samples collected after 12 Noon, 12 hours may be added to the Report Turn Around TimeHard Copy : Delivered at home upon request. A small convenience fee may apply.

Why it is Done

To help diagnose and monitor the treatment of chronic myelogenous leukaemia (CML) and a type of acute lymphoblastic leukaemia (ALL).

What is this test

BCR-ABL1 refers to a sequence found in an abnormal chromosome 22 of some people with certain forms of leukaemia. Unlike most cancers, the cause of chronic myelogenous leukaemia (CML) and some other leukaemia can be traced to a single, specific genetic abnormality in one chromosome. The presence of the gene sequence known as BCR-ABL1 confirms the diagnosis of CML and a form of acute lymphoblastic lymphoma (ALL).